Opportunity Information: Apply for RFA DA 10 004
Apply for RFA DA 10 004
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Economic Studies of Health Insurance Coverage on Drug Abuse Treatment Availability, Access, Costs, and Quality (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Apr 7, 2009 and posted on Apr 7, 2009.
- Applicants must submit their applications by Jul 14, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Native American tribal organizations (other than Federally recognized tribal governments) State governments City or township governments Others (see text field entitled Additional Information on Eligibility for clarification) Private institutions of higher education Public and State controlled institutions of higher education Special district governments Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) County governments For profit organizations other than small businesses.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The funding opportunity titled "Economic Studies of Health Insurance Coverage on Drug Abuse Treatment Availability, Access, Costs, and Quality (R01)" (Funding Opportunity Number RFA-DA-10-004) is a National Institutes of Health initiative led by the National Institute on Drug Abuse (NIDA). Its main goal is to support rigorous, theory-driven economic and policy research that examines how recent legislative and regulatory changes have altered health insurance coverage for drug abuse treatment services. In practical terms, the program is looking for research that can clearly explain whether changes in insurance rules are shaping the real-world treatment landscape, including how many services are available, who can actually access them, what they cost, and whether the quality of care improves or declines as coverage policies shift.
This opportunity uses the NIH Research Project Grant mechanism (R01), which is designed for substantial, multi-year research projects that can produce strong empirical findings. The emphasis on "rigorous" and "theory-driven" work signals that NIDA expects applicants to use sound conceptual frameworks and credible methods, such as policy analysis, econometric modeling, quasi-experimental designs, claims and administrative data analysis, or other approaches that can isolate the effects of coverage-related changes from other influences. The research focus is not just on insurance in the abstract, but on downstream outcomes in treatment systems and patient experiences, such as service capacity, utilization patterns, affordability, and measurable aspects of care quality.
NIDA anticipated committing about $2,000,000 in total costs (meaning direct costs plus facilities and administrative costs) in fiscal year 2010 to support this program. The agency expected to make roughly 4 to 5 new awards under this announcement. The listed award ceiling is $500,000, which provides a sense of the upper range of funding per project within the structure of the total program budget.
The opportunity is categorized as discretionary funding and is offered as a grant within the education and health activity area. The associated CFDA number is 93.279, which corresponds to Drug Abuse and Addiction Research Programs. There is no cost sharing or matching requirement, meaning applicants are not required to contribute their own funds to receive an award.
Eligibility is broad and includes many types of organizations that typically participate in NIH funding, spanning public and private institutions of higher education, nonprofit organizations (including both 501(c)(3) and certain non-501(c)(3) nonprofits), small businesses, and for-profit organizations (other than small businesses). It also includes multiple levels of government entities such as state governments, county governments, city or township governments, special district governments, and public housing authorities/Indian housing authorities. The eligibility list also explicitly includes Native American tribal governments (federally recognized) and Native American tribal organizations (other than federally recognized tribal governments).
In addition, the announcement notes other eligible applicants such as historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, faith-based and community-based organizations, eligible federal agencies, U.S. territories or possessions, regional organizations, and non-U.S. entities (foreign organizations). This wide eligibility range suggests NIDA wanted to encourage participation from diverse research environments, including policy groups and community-linked organizations, provided the proposed work meets the scientific and methodological expectations of an NIH R01.
Key dates indicate the opportunity was posted and created on April 7, 2009, with an original and current closing date of July 14, 2009, and an archive date of August 14, 2009. The administering agency is the National Institutes of Health, and the announcement points applicants to the full FOA details via the NIH grants guide link (http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-10-004.html). For technical access issues, the listed contact is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Overall, this R01 opportunity was designed to generate policy-relevant evidence on how insurance coverage rules and reforms affect the drug abuse treatment system, with specific attention to availability, access, costs, and quality. The intent is to fund studies that can inform decision-making by producing credible findings about whether coverage expansions or regulatory changes translate into meaningful improvements (or unintended consequences) in treatment delivery and outcomes.
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The funding opportunity is titled "Economic Studies of Health Insurance Coverage on Drug Abuse Treatment Availability, Access, Costs, and Quality (R01)."
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is RFA-DA-10-004.
Which agency is offering this grant?
This is a National Institutes of Health (NIH) funding opportunity led by the National Institute on Drug Abuse (NIDA).
What is the main purpose of this grant opportunity?
The goal is to support rigorous, theory-driven economic and policy research on how legislative and regulatory changes have altered health insurance coverage for drug abuse treatment services, and how those insurance changes affect treatment availability, access, costs, and quality.
What kinds of research questions is NIDA trying to answer through this program?
The program is looking for studies that can credibly explain whether changes in insurance coverage rules are shaping real-world drug abuse treatment systems, including:
- How many treatment services are available (service availability/capacity)
- Who can access services in practice (access and utilization)
- What services cost and how affordable they are (costs/affordability)
- Whether measurable quality of care improves or declines (quality)
What grant mechanism is used for this opportunity?
This opportunity uses the NIH Research Project Grant mechanism (R01), intended for substantial, multi-year research projects that can produce strong empirical findings.
What does NIDA mean by "rigorous" and "theory-driven" research in this FOA?
Based on the description provided, NIDA is emphasizing studies built on sound conceptual frameworks and credible methods capable of isolating the effects of insurance coverage changes from other influences. Examples of approaches mentioned include policy analysis, econometric modeling, quasi-experimental designs, and analysis of claims and administrative data.
Is this opportunity focused on health insurance in general, or on downstream treatment outcomes?
It is specifically focused on downstream outcomes in drug abuse treatment systems and patient experiences, such as service capacity, utilization patterns, affordability, and measurable aspects of care quality, as insurance coverage policies shift.
How much funding did NIDA plan to commit to this program?
NIDA anticipated committing about $2,000,000 in total costs in fiscal year 2010 to support this program.
How many awards were expected under this announcement?
The agency expected to make roughly 4 to 5 new awards.
What is the maximum award amount mentioned for a single project?
The listed award ceiling is $500,000, which indicates the upper range of funding per project within the total program budget described.
Does the stated funding amount refer to direct costs only?
No. The $2,000,000 figure is described as total costs, meaning direct costs plus facilities and administrative (F&A) costs.
Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
What type of funding is this categorized as?
It is categorized as discretionary funding and is offered as a grant within the education and health activity area.
What is the CFDA number for this program?
The associated CFDA number is 93.279, corresponding to Drug Abuse and Addiction Research Programs.
Who is eligible to apply?
Eligibility is broad and includes many organization types, including:
- Public and private institutions of higher education
- Nonprofit organizations (including 501(c)(3) and certain non-501(c)(3) nonprofits)
- Small businesses
- For-profit organizations (other than small businesses)
- State, county, city or township governments
- Special district governments
- Public housing authorities / Indian housing authorities
- Native American tribal governments (federally recognized)
- Native American tribal organizations (other than federally recognized tribal governments)
Are minority-serving institutions mentioned as eligible?
Yes. The eligibility list explicitly includes historically Black colleges and universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), and Alaska Native and Native Hawaiian-serving institutions.
Are faith-based and community-based organizations eligible?
Yes. The opportunity explicitly includes faith-based and community-based organizations among eligible applicants.
Can federal agencies apply?
Yes. The eligibility list includes eligible federal agencies.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are listed as eligible applicants.
Are regional organizations eligible?
Yes. Regional organizations are listed among eligible applicants.
Are non-U.S. organizations eligible to apply?
Yes. The eligibility list includes non-U.S. entities (foreign organizations).
When was the opportunity posted?
The opportunity was posted and created on April 7, 2009.
What was the application deadline?
The original and current closing date was July 14, 2009.
When was the opportunity archived?
The archive date was August 14, 2009.
Where can applicants find the full FOA details?
The announcement points to the NIH Grants Guide link for full details: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-10-004.html
Who should be contacted for technical access issues?
For technical access issues, the listed contact is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
What is the intended impact of the research funded under this FOA?
The intent is to generate policy-relevant evidence about whether insurance coverage expansions or regulatory changes translate into meaningful improvements (or unintended consequences) in drug abuse treatment delivery and outcomes, specifically around availability, access, costs, and quality.
Is this opportunity specifically described as an NIH initiative?
Yes. It is described as a National Institutes of Health initiative led by NIDA.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: National Quality Improvement Center on the Representation of Children in the Child Welfare System
Previous opportunity: Small Business Innovation Research (SBIR) Program CFDA 84.133S
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 10 004
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 10 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Studies of Energy Balance and Cancer in Humans (R01) Apply for PA 09 148 Funding Number: PA 09 148 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Studies of Energy Balance and Cancer in Humans (R21) Apply for PA 09 149 Funding Number: PA 09 149 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (P01) Apply for PAR 09 147 Funding Number: PAR 09 147 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| In vivo Cellular and Molecular Imaging Centers (ICMICs) (P50) Apply for PAR 09 157 Funding Number: PAR 09 157 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,250,000 |
| NLM Applied Informatics Grants (G08) Apply for RFA LM 09 001 Funding Number: RFA LM 09 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Developmental Research in Cancer Prognosis and Prediction (R21) Apply for PA 09 158 Funding Number: PA 09 158 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Developmental Research in Cancer Prognosis and Prediction (R33) Apply for PA 09 159 Funding Number: PA 09 159 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) Apply for PAR 09 160 Funding Number: PAR 09 160 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Basic Cancer Research in Cancer Health Disparities (U01) Apply for PAR 09 161 Funding Number: PAR 09 161 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Developmental Projects in Complementary Approaches to Cancer Care and Treatment (R21) Apply for PA 09 167 Funding Number: PA 09 167 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Developmental Projects in Complementary Approaches to Cancer Care and Treatment (R03) Apply for PA 09 168 Funding Number: PA 09 168 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Minority Based Community Clinical Oncology Program (U10) Apply for RFA CA 09 023 Funding Number: RFA CA 09 023 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Renewal of Centers of Biomedical Research Excellence (COBRE)P20 Apply for PAR 09 180 Funding Number: PAR 09 180 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Centers of Biomedical Research Excellence (COBRE) Phase III Transitional Centers P30 Apply for RFA RR 09 005 Funding Number: RFA RR 09 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $750,000 |
| Community Clinical Oncology Program (U10) Apply for RFA CA 09 022 Funding Number: RFA CA 09 022 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Technologies and Software to Support Integrative Cancer Biology Research (SBIR) R43/R44 Apply for PA 09 188 Funding Number: PA 09 188 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) R43/R44 Apply for PA 09 187 Funding Number: PA 09 187 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Technology for the Detection and Characterization of Low Abundance Proteins, Peptides, or micro RNAs (SBIR) R43/R44 Apply for PA 09 189 Funding Number: PA 09 189 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Integrating Translational Neuroscience and Adolescent Drug Abuse Treatment (R21) Apply for RFA DA 10 003 Funding Number: RFA DA 10 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| International Research Collaborations on HIV/AIDS and Drug Use (R01) Apply for RFA DA 10 008 Funding Number: RFA DA 10 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 10 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.